Stock Information
Trevi Therapeutics Inc (TRVI)
Ticker Symbol: TRVI
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $2,121.12 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.3234
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -24.53%
Latest News
-
This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday
Tue, Jul 21, 2026 11:14 AM
-
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Tue, Jul 21, 2026 7:58 AM
-
BMO Capital Initiates Coverage On Trevi Therapeutics with Outperform Rating, Announces Price Target of $36
Tue, Jul 21, 2026 6:06 AM
-
B. Riley Securities Maintains Buy on Trevi Therapeutics, Raises Price Target to $31
Mon, Jul 20, 2026 9:36 AM
-
Global Payments To Rally More Than 28%? Here Are 10 Top Analyst Forecasts For Monday
Mon, Jul 20, 2026 7:40 AM
-
HC Wainwright & Co. Maintains Buy on Trevi Therapeutics, Raises Price Target to $24
Mon, Jul 20, 2026 6:49 AM
Key Financials
Financial data not available
